Profile
SEEL VRTX REGN SGEN ALNY ARGX
Company Name Seelos Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $214.97K $116.96B $58.10B $43.15B $41.50B $33.28B
Employees 0.01K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Raj Mehra Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
SEEL VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 2
Quant Rating Sell Sell Buy Neutral Strong Sell Sell
Trading
SEEL VRTX REGN SGEN ALNY ARGX
Last Close $0.37 $459.62 $547.36 $228.74 $331.91 $543.48
High 52 $3.9 $516.74 $1201.76 $228.74 $331.91 $671.75
Low 52 $0.19 $396.64 $482.92 $228.74 $224.58 $435.84
Price vs. 52 Week High -90.51 % -11.05 % -54.45 % 0 % 0 % -19.09 %
Price vs. 52 Week Low 94.74 % 15.88 % 13.34 % 0 % 47.79 % 24.7 %
Total Return
SEEL VRTX REGN SGEN ALNY ARGX
1 Month Return 0 % 2.02 % 10.98 % 0 % 10.33 % -7.24 %
3 Month Return 0 % -3.16 % -4.55 % 0 % 40.79 % -2.1 %
6 Month Return 0 % 14.19 % -23.58 % 0 % 42.36 % -15.79 %
9 Month Return -89.15 % 0.95 % -45.96 % 0 % 23.85 % 2.55 %
YTD Return 0 % 14.13 % -23.16 % 0 % 41.05 % -11.63 %
1 Year Return -33.33 % -3.15 % -47.08 % 0 % 32.22 % 24.7 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SEEL VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
SEEL VRTX REGN SGEN ALNY ARGX
Asset Growth -76.18 % -0.87 % 36.55 %
Gross Profit Growth -52567.92 % 10.25 % 77.08 %
Revenue Growth - 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year -97.95 % 1632.15 % 5950.81 %
EBIT Growth 48.58 % -93.69 % 128.87 %
Net Income Growth 50.25 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 39.98 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 91.41 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share 94.76 % 33.84 % 938.02 %
Operating Income Growth 42.89 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) 61.18 % -113.93 % 80.31 %
Operating 3 Year CFG 65.18 % -118.65 % 88.36 %
Operating 5 Year CFG 93.83 % -131.3 % -135.21 %
Operating 10 Year CFG 96.28 % 12.43 % -64 %
EPS Growth 64.01 % -114.8 % 369.77 %
EPS Diluted Growth 64.01 % -114.97 % 347.67 %
Book Value Per Share -128.45 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -496.75 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -127.31 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share -107.15 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -29.29 % 116.42 % 95.27 %
Free Cash Flow Growth 61.18 % -124.1 % 67.46 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024
Profitability
SEEL VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 51.18 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -269.09 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM 20.29 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM 61.16 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 37.24 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM -1069.96 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -74.09 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM 8.55 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 0.05 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM 3421.28 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM 67.53 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -8.71 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -8.71 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 34.01 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -467.97 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -74.09 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.03 -92.97 19.24 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM -0.04 -119.36 14.77 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM -0.04 -119.36 14.77 -93.1 -914.84 -515.98
Income Statement (TTM)
SEEL VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $-0.03B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio -1267.09% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.04B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.04B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -7.73 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
SEEL VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.04B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $-0.03B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0.01B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.01B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
SEEL VRTX REGN SGEN ALNY ARGX
Net Income $-0.04B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 42.85
AARD Aardvark Therapeutics, Inc. Common Stock 13.92
ABCL AbCellera Biologics Inc. 3.8
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.89
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.16
ABPWW 0.0222
ABSI Absci Corporation 2.77
ABUS Arbutus Biopharma Corporation 3.24
ABVC ABVC BioPharma, Inc. 3.11
ABVX Abivax SA American Depositary Shares 7.96
ACAD ACADIA Pharmaceuticals Inc. 20.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.607
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.18
ACIU AC Immune SA 2.07
ETFs With Exposure to SEEL
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 308.03
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 136.82
VXF Vanguard Extended Market Index Fund 0 197.5
XAW.TO iShares Core MSCI All Country World ex Canada Index ETF 0 46.43
XUU.TO iShares Core S&P U.S. Total Market Index ETF 0 62.4
XUH.TO iShares Core S&P U.S. Total Market Index ETF (CAD-Hedged) 0 50.61
XTR.TO iShares Diversified Monthly Income ETF 0 11.37
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.8
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.79
XBAL.TO iShares Core Balanced ETF Portfolio 0 31.16
XCNS.TO iShares Core Conservative Balanced ETF Portfolio 0 24.07
XEQT.TO iShares Core Equity ETF Portfolio 0 35.8
XGRO.TO iShares Core Growth ETF Portfolio 0 31.96
XINC.TO iShares Core Income Balanced ETF Portfolio 0 20.69
VTSAX Vanguard Total Stock Market Index Fund 0 150.01
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 149.82
VITSX Vanguard Total Stock Market Index Fund 0 150.04
IBRN iShares Neuroscience and Healthcare ETF 0.0146 22.3566
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000308553 106.14
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 149.83
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
PSIL AdvisorShares Psychedelics ETF 0.16 14.44
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0 369.73
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 281.45
Unlock